The cost of diabetic foot ulcers and amputations to the National Health Service in England.
Marion KerrE BarronP ChadwickT EvansW M KongG RaymanM Sutton-SmithG ToddB YoungWilliam J JeffcoatePublished in: Diabetic medicine : a journal of the British Diabetic Association (2019)
Diabetic foot care accounts for a substantial proportion of healthcare expenditure in England, more than the combined cost of breast, prostate and lung cancers. Much of this expenditure arises through prolonged and severe ulceration. If the NHS were to reduce the prevalence of diabetic foot ulcers in England by one-third, the gross annual saving would be more than £250 million. Diabetic foot ulceration is a large and growing problem globally, and it is likely that there is potential to improve outcomes and reduce expenditure in many countries.